New drug aims to shrink nasal polyps and ease breathing
NCT ID NCT06516302
Summary
This study is testing whether a new injectable drug called GR1802 can help adults with severe chronic sinusitis and nasal polyps. Researchers want to see if the drug can shrink polyps, improve breathing and smell, and reduce the need for surgery or steroid pills. Over 200 participants will receive either GR1802 or a placebo injection every two weeks for 13 months while tracking their symptoms.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHRONIC RHINOSINUSITIS WITH NASAL POLYPS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Beijing Tongren Hospital, Capital Medical University
Beijing, China
Conditions
Explore the condition pages connected to this study.